| Dr Joshua Vansluyters, DO | |
|
5900 Byron Center Ave Sw, Wyoming, MI 49519-9606 | |
| (616) 252-7200 | |
| Not Available |
| Full Name | Dr Joshua Vansluyters |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 7 Years |
| Location | 5900 Byron Center Ave Sw, Wyoming, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093235848 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 5101023575 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Metro Health Hospital | Wyoming, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Certified Emergency Medicine Specialists Pc | 6204802895 | 15 |
News Archive
Ischemic stroke patients treated on a mobile stroke unit received anti-clot medication faster and ended up with less disability at 90 days, according to a study published today in the New England Journal of Medicine led by researchers at The University of Texas Health Science Center at Houston and Memorial Hermann-Texas Medical Center.
A combination of diagnostic tests, including imaging and cerebrospinal fluid biomarkers can improve prediction of conversion from mild cognitive impairment (MCI) to Alzheimer's disease, according to a new study published online in the journal Radiology.
Driver Aric Almirola is lending his voice to a national public education program to raise awareness of actinic keratosis (AK) - a potential early warning sign of skin cancer - as well as the long-term consequences of sun damage over a lifetime. The national campaign, "Is it AK or OK?" is sponsored by Graceway Pharmaceuticals, LLC, in partnership with The Skin Cancer Foundation.
Cancer epidemiologists at the University at Buffalo have identified specific genes that are most likely to become cancer promoters when exposed to a process called DNA promoter hypermethylation.
Researchers from the Banner Alzheimer's Institute (BAI) today announced a partnership with Novartis in a pioneering medical trial to determine whether two investigational anti-amyloid drugs-an active immunotherapy and an oral medication-can prevent or delay the emergence of symptoms of Alzheimer's in people at particularly high risk for developing the disease at older ages.
› Verified 2 days ago
| Entity Name | Metropolitan Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811937519 PECOS PAC ID: 5597651836 Enrollment ID: O20040507000012 |
News Archive
Ischemic stroke patients treated on a mobile stroke unit received anti-clot medication faster and ended up with less disability at 90 days, according to a study published today in the New England Journal of Medicine led by researchers at The University of Texas Health Science Center at Houston and Memorial Hermann-Texas Medical Center.
A combination of diagnostic tests, including imaging and cerebrospinal fluid biomarkers can improve prediction of conversion from mild cognitive impairment (MCI) to Alzheimer's disease, according to a new study published online in the journal Radiology.
Driver Aric Almirola is lending his voice to a national public education program to raise awareness of actinic keratosis (AK) - a potential early warning sign of skin cancer - as well as the long-term consequences of sun damage over a lifetime. The national campaign, "Is it AK or OK?" is sponsored by Graceway Pharmaceuticals, LLC, in partnership with The Skin Cancer Foundation.
Cancer epidemiologists at the University at Buffalo have identified specific genes that are most likely to become cancer promoters when exposed to a process called DNA promoter hypermethylation.
Researchers from the Banner Alzheimer's Institute (BAI) today announced a partnership with Novartis in a pioneering medical trial to determine whether two investigational anti-amyloid drugs-an active immunotherapy and an oral medication-can prevent or delay the emergence of symptoms of Alzheimer's in people at particularly high risk for developing the disease at older ages.
› Verified 2 days ago
| Entity Name | Certified Emergency Medicine Specialists Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104985001 PECOS PAC ID: 6204802895 Enrollment ID: O20040908001374 |
News Archive
Ischemic stroke patients treated on a mobile stroke unit received anti-clot medication faster and ended up with less disability at 90 days, according to a study published today in the New England Journal of Medicine led by researchers at The University of Texas Health Science Center at Houston and Memorial Hermann-Texas Medical Center.
A combination of diagnostic tests, including imaging and cerebrospinal fluid biomarkers can improve prediction of conversion from mild cognitive impairment (MCI) to Alzheimer's disease, according to a new study published online in the journal Radiology.
Driver Aric Almirola is lending his voice to a national public education program to raise awareness of actinic keratosis (AK) - a potential early warning sign of skin cancer - as well as the long-term consequences of sun damage over a lifetime. The national campaign, "Is it AK or OK?" is sponsored by Graceway Pharmaceuticals, LLC, in partnership with The Skin Cancer Foundation.
Cancer epidemiologists at the University at Buffalo have identified specific genes that are most likely to become cancer promoters when exposed to a process called DNA promoter hypermethylation.
Researchers from the Banner Alzheimer's Institute (BAI) today announced a partnership with Novartis in a pioneering medical trial to determine whether two investigational anti-amyloid drugs-an active immunotherapy and an oral medication-can prevent or delay the emergence of symptoms of Alzheimer's in people at particularly high risk for developing the disease at older ages.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joshua Vansluyters, DO 5900 Byron Center Ave Sw, Wyoming, MI 49519-9606 Ph: () - | Dr Joshua Vansluyters, DO 5900 Byron Center Ave Sw, Wyoming, MI 49519-9606 Ph: (616) 252-7200 |
News Archive
Ischemic stroke patients treated on a mobile stroke unit received anti-clot medication faster and ended up with less disability at 90 days, according to a study published today in the New England Journal of Medicine led by researchers at The University of Texas Health Science Center at Houston and Memorial Hermann-Texas Medical Center.
A combination of diagnostic tests, including imaging and cerebrospinal fluid biomarkers can improve prediction of conversion from mild cognitive impairment (MCI) to Alzheimer's disease, according to a new study published online in the journal Radiology.
Driver Aric Almirola is lending his voice to a national public education program to raise awareness of actinic keratosis (AK) - a potential early warning sign of skin cancer - as well as the long-term consequences of sun damage over a lifetime. The national campaign, "Is it AK or OK?" is sponsored by Graceway Pharmaceuticals, LLC, in partnership with The Skin Cancer Foundation.
Cancer epidemiologists at the University at Buffalo have identified specific genes that are most likely to become cancer promoters when exposed to a process called DNA promoter hypermethylation.
Researchers from the Banner Alzheimer's Institute (BAI) today announced a partnership with Novartis in a pioneering medical trial to determine whether two investigational anti-amyloid drugs-an active immunotherapy and an oral medication-can prevent or delay the emergence of symptoms of Alzheimer's in people at particularly high risk for developing the disease at older ages.
› Verified 2 days ago
Dr. John S Bradley, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 5900 Byron Center Sw, Metro Health Hospital, Wyoming, MI 49519 Phone: 616-363-7123 | |
Dr. Daniel Hearld, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 5900 Byron Center Ave Sw, Metro Health Hospital, Wyoming, MI 49519 Phone: 616-363-7867 Fax: 616-363-9432 | |
Dr. Adam Passeno, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 5900 Byron Center Sw, Metro Health Hospital, Wyoming, MI 49519 Phone: 616-252-7123 | |
Dr. Dana Danielle Hop, D.O Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 5900 Byron Center Ave Sw, Wyoming, MI 49519 Phone: 616-252-7200 | |
Dr. Jennifer Gail Collins, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 5900 Byron Center Ave Sw, Wyoming, MI 49519 Phone: 616-252-7200 | |
Dr. Anil Kumar Pillay, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 5900 Byron Center Ave Sw, Wyoming, MI 49519 Phone: 616-252-7419 Fax: 616-252-0133 |